Aclaris Therapeutics ACRS
- ATI-052 — Atopic Dermatitis Phase 1
- ATI-052 — Asthma Phase 1
IL-4R (3 companies · 5 programs)
Companies with an active program directed at IL-4R.
Medicenna Therapeutics Corp. MDNAF
- bizaxofusp — Recurrent Glioblastoma Phase 2
- MDNA413 Preclinical
Apogee Therapeutics, Inc. APGE
- APG808 — Asthma Phase 1